Gene Query: SEPT3

Dataset Description Geneva Score
Dual modulation of neuron specific microRNAs and the REST complex promotes functional maturation of induced human adult neurons 60.14
Transcriptomic Profiling of Developing Human Paraxial Mesoderm from 4.5-5 Weeks of Gestation Human Embryos 59.35
Integrative analysis identifies targetable CREB1/FoxA1 transcriptional co-regulation as a predictor of prostate cancer recurrence 58.46
Transcriptome profiling of a mouse model of alveolar soft part sarcoma 56.76
Identifying ASCL1 target genes in primary GBM stem cell cultures [RNA-seq] 55.65
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression 54.13
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression [RNA-seq] 54.13
ELF4 is a target of miR-124 and promotes neuroblastoma proliferation and undifferentiated state 48.82
DJ-1 is dispensable for human stem cell homeostasis 45.89
Effect of Hypoxia in Severe Preeclampsia through Epigenetic Regulation 45.27
Effect of the knockdown of MLL1 and MLL2 on pediatric high grade glioma 42.65
SMN deficiency in spinal muscular atrophy causes widespread intron retention and DNA damage 42.3
In vitro differentiation of human low threshold mechanoreceptive (LTMR) neurons from embryonic stem cells 39.68
BAF controls genome accessibility 38.91
Rescue of Fragile X syndrome neurons by DNA methylation editing of the FMR1 gene [RNA-seq] 36.39
Rescue of Fragile X syndrome by DNA methylation editing of the FMR1 36.39
Epigenomic landscape during organ formation in human early embryos 35.47
PTEN suppresses neoplastic transformation of human neural stem cells by transcriptional repression of Pax7 35.32
AR-independent prostate cancer is sustained through FGF signaling 35.11
REST and Neural Gene Network Dysregulation in iPS Cell Models of Alzheimer’s Disease (RNA-seq data set) 33.53
REST and Neural Gene Network Dysregulation in iPS Cell Models of Alzheimer’s Disease 33.53
Effect of disulfiram treatment on pediatric high grade glioma 33.39
Engineered human pluripotent stem cell-derived intestinal tissues with a functional enteric nervous system 33.39
Recapitulation of Human Neural Microenvironment Signatures in iPSC-Derived NPC 3D Differentiation 32.61
Restoration of Progranulin Expression Rescues Cortical Neuron Generation in Induced Pluripotent Stem Cell Model of Frontotemporal Dementia 31.46
DIGIT regulates endoderm differentiation of human embryonic stem cells 30.51
Human iPSC-derived cells and microengineered Organ-Chip enhance neural development. 28.21
Telomere-Dependent and Telomere-Independent Roles of RAP1 in Regulating Human Stem Cell Homeostasis 28.08
Parkinson’s Disease Genetic Risk in a Midbrain Neuronal Cell Line 27.48
Expression profiling by high throughput sequencing of tumors derived from human prostate epithelial cells transformed with the oncogenes N-Myc and myrAKT1. 27.37
Generation of induced neural stem cells from urine derived cells by synthetic mRNA 26.62
Regionally distinct astrocyte interferon signaling promotes blood-brain barrier integrity and limits immunopathology during neurotropic viral infection 25.56
SMUG1 promotes telomere maintenance through telomerase RNA end-processing 25.32
SOX10 Single Transcription Factor Based Fast and Efficient Generation of Oligodendrocytes from Human Pluripotent Stem Cells 23.81
A peninsular structure coordinates asynchronous differentiation with morphogenesis to generate pancreatic islets [bulk vs buds] 23.52
circRNA-sequencing 23.38
Capturing the biology of mild versus severe disease in a pluripotent stem cell-based model of Familial Dysautonomia 22.79
Analysis of the Clustered Protocadherin (cPcdh) Locus in Human Pluripotent Stem and Derived Cells [RNA-seq II our of II] 22.73
Expression profile of HNF1A knockdown and overexpression in 22RV1 and LNCaP cells respectively 22.4
A Brain Penetrant Mutant IDH1 Inhibitor Provides In Vivo Survival Benefit 22.32
A SIRT1-centered Circuitry Regulates Breast Cancer Stemness and Metastasis 22.24
Patient iPSC-derived neural stem cells display progressive enlargement of lysosomes and disruptions of glycosaminoglycan pathway and autophagy in concordance with clinical severity of Mucopolysaccharidosis I 21.94
Total RNA sequencing of WT intestinal orgaonids. 21.83
Multiple mechanisms disrupt let-7 miRNA biogenesis and function in neuroblastoma [longRNA] 21.28
Progressive motor neuron pathology and the role of astrocytes in a human stem cell model of VCP-related ALS 20.84
PRRX2 and HEY2 double knock-down facilitates ASCL1-induced neuron conversion in human dermal fibroblasts. 20.81
RNA Sequencing of default, melanocyte biased and enteric human neural crest populations (NC) and neuroectoderm (CNS) 20.43
Analyzing the interactions of mRNAs, miRNAs, lncRNAs and circRNAs to predict competing endogenous RNA networks in glioblastoma 20.14
Total RNA sequencing of APC mutant and wt colonic organoids 20.06
Temporal activation of NR5A2 and RARγ induce functional human naïve pluripotent state via modulating TGFβ pathway 20.02
Targeted reactivation of FMR1 transcription in FXS embryonic stem cells 19.72
Transcriptome analysis of small molecule-mediated astrocyte-to-neuron reprogramming 19.57
Combined Experimental and System-Level Analyses Reveal the Complex Regulatory Network of miR-124 during Human Neurogenesis [ZNF787] 19.24
Comprehensive evaluation of differential gene expression analysis methods for RNA-seq data 19.19
Transcriptome analysis of virus infected tissues 19.08
Activation of neuronal genes via LINE-1 elements upon global DNA demethylation in human neural progenitors 19.07
RNA-seq and ChIP-seq analysis of BMI1 or RING1B-silenced prostate cancer cells C4-2 19.03
Appropriately Differentiated ARPE-19 Cells Regain a Native Phenotype and Similar Gene Expression Profile 18.68
HDAC inhibition enhances the in vivo efficacy of MEK inhibitor therapy in uveal melanoma 18.51
Heterozygous mutations in SMARCA2 lead to impaired neurogenesis due to global retargeting of SMARCA4 18.45
RNA-seq Transcriptome Analysis of AD169 and AD169-ΔUL26 infected MRC5 fibroblasts. 18.44
Prospective Isolation and Comparison of Human Germinal Matrix and Glioblastoma EGFR+ Populations with Stem Cell Properties 18.37
Differential expression of human parthenogenic stem cells, neural stem cells and DA progenitors. 18.32
FUS mutant human motoneurons transcriptome analysis reveals altered pathways and impairment of microRNA function 17.35
RNA Sequencing Reveals Immunosuppressive Role of Anthrax Lethal Toxin in Human Lung Epithelial and Monocytic Cells 17.03
LMO1 Synergizes with MYCN to Promotes Neuroblastoma Initiation and Metastasis 16.88
RNA-seq analysis of control and ZC3H18-depleted ovarian cancer cells 16.74
mRNA-sequencing of 293T-no dice transfected with miR-16, miR-214, or KSHV-miR-K6-5p 16.74
Gene expression analysis of human haploid cells (HAP1) depleted of SMARCB1 and SMARCA4 16.66
Hsa-miR-371a-5p and hsa-miR-518a-3p regulated genes in choriocarcinoma cells 16.36
Characterization of sperm lncRNA and its differently expression in the sperm of asthenozoospermic patients 16.3
Expression charcaterization of an internal protocol developed to differentiate RPE cells 16.28
In vitro differentiation of human embryonic stem cells into ovarian follicle-like cells 16.11
Induction of human SST and PV neurons by expressing a single transcription factor LHX6 15.97
Amiloride, an old diuretic drug, is a potential therapeutic agent for multiple myeloma 15.74
Arginine methylation controls cell proliferation by integrating E2F activity with the splicing machinery (RNA-seq data set) 15.73
Arginine methylation controls cell proliferation by integrating E2F activity with the splicing machinery 15.73
Mapping cis-regulatory chromatin contacts in neural cells links neuropsychiatric disorder risk variants to target genes 15.69
Mapping cis-regulatory chromatin contacts in neural cells links neuropsychiatric disorder risk variants to target genes [RNA-Seq] 15.69
Species-specific maturation profiles of human, chimpanzee and bonobo neural cells 15.6
NGS based identification of GD2-positive tumor-specific phenotype for cancer diagnostics and therapy 15.26
Metabolic Reprogramming Associated with Aggressiveness Occurs in the G-CIMP-High Molecular Subtypes of IDH1mut Lower Grade Gliomas 15.26
RNA sequencing of BT142 and TS603 cell lines 15.26
Universal alternative splicing of noncoding exons 15.19
Verification and rectification of cell type-specific splicing of a Seckel syndrome-associated ATR mutation using iPS cell model 15.14
Lipid catabolism inhibition sensitizes prostate cancer cells to antiandrogen blockade 15.09
Disease modelling of core pre-mRNA splicing factor haploinsufficiency 14.98
Multiple mechanisms disrupt let-7 miRNA biogenesis and function in neuroblastoma 14.73
Robust generation of honemogeneous midbrain organoids with in vivo–like cellular composition facilitates neurotoxin-based Parkinson’s disease modeling 14.58
RNA-sequencing of human peripheral blood mononuclear cells (PB MNCs) and induced neural progenitor cells derived from PB MNCs 14.53
Self-organized amniogenesis by human pluripotent stem cells in a biomimetic implantation-like niche 14.4
Adaptive chromatin remodeling in glioblastoma stem cell plasticity and drug tolerance 14.38
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-Seq] 14.32
JMJD3 and UTX Determine Fidelity and Lineage Specification of Human Neural Progenitor Cells [RNA-seq] 14.31
JMJD3 and UTX Determine Fidelity and Lineage Specification of Human Neural Progenitor Cells 14.31
Transcriptional alteration after ionizing radiation exposure in human fibroblasts, iPSCs and NPCs 14.23
nELAVL HITS-CLIP in Alzheimer's Disease patients 14.19
POLR3G Dependent PolyA+ and smallRNA Transcriptomes in Human Pluripotent Stem Cells 14.16
Analysis of MGE Transcriptomes with or without Ctnnb1 knockout in human through RNA Sequencing 14.06
Alteration of the microRNA network during the progression of Alzheimer’s disease 13.88
Primary human trophoblast from term placenta 13.83
RNA-sequencing of Wnt-dependent and Wnt-independent of Glioblastoma stem cell cultures 13.81
Next Generation Sequencing Facilitates Quantitative Analysis of Retinoblastoma Transcriptomes 13.78
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock [RNA-Seq] 13.71
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock 13.71
Expression profile of LNCaP/AR cells with or without HNF4G expression grown for long term in charcoal stripped-serum (CSS) media 13.65
Human germ cell formation in xenotransplants of induced pluripotent stem cells carrying X chromosome aneuploidies 13.62
Repurposing of promoters and enhancers during mammalian evolution 13.57
MYT1 attenuates neuroblastoma cell differentiation by inhibiting retinoic acid signaling pathway 13.21
BI Human Reference Epigenome Mapping Project 13.03
Genetic Tagging During Human Mesoderm Differentiation Reveals Tripotent Lateral Plate Mesodermal Progenitors 13.01
mRNA sequencing of clinical-grade neural stem cells derived from human ES cells 13.0
EGFR Mutation Promotes Glioblastoma Through Epigenome and Transcription Factor Network Remodeling 12.85
Gene expression profiling via RNA sequencing of patient brain tumors cultured in 3D bioengineered cultures 12.73
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation [cPDS-RNA-seq] 12.67
Epigenetic silencing of the tumor suppressor RASSF4 favors multiple myeloma progression 12.32
RNA-Seq study of Cell lines rendered resistant to idelalisib and ibrutinib 12.3
FUS KO mRNA sequencing and anti-FUS RNA immunoprecipitation sequencing 12.22
PNET animal model: new insights (II) 11.93
Differentially expressed (DE) genes analysis in synovial fluid mesenchymal stem cells (SF-MSCs), SF-MSC derived iPSCs and iPSC derived MSCs (iPSC-MSCs) 11.92
Nuclear import of the DSCAM-cytoplasmic domain drives signaling capable of inhibiting synapse formation 11.91
Systematic analysis of gene expression profiles controlled by hnRNP Q and hnRNP R, two closely related human heterogeneous nuclear ribonucleoproteins. 11.82
MUC1-C Drives Lineage Plasticity in Progression to Neuroendocrine Prostate Cancer 11.75
Gata6 potently initiates reprogramming of pluripotent and differentiated cells to extraembryonic endoderm stem cells [ChIP-Seq & RNA-Seq] 11.63
Gata6 potently initiates reprogramming of pluripotent and differentiated cells to extraembryonic endoderm stem cells 11.63
RNA Sequencing Analysis of villus tissues from unexplained recurrent spontaneous abortion patients and controls with induced abortions 11.63
Androgen Receptor-regulated genes in prostate cancer cells 11.5
RNA-seq profiling identifies Androgen Receptor-regulated genes in prostate cancer cells 11.5
Examining serotonergic neuron differentiation from human iPSCs 11.47
EP400 is required for Max and MCPyV mediated gene activation 11.39
Functional astrocytes differentiated from hiPSCs 11.32
RNA sequencing for PDX1, NGN3 and MAFA transduced iPSCs cell 11.25
Transcriptome of iPSC-derived Neural Cells with Heterozygous Knockout in CHD8 11.25
Role of miR-146a in neural stem cell differentiation and neural lineage determination: relevance for neurodevelopmental disorders 11.2
RNA-seq of hiPSCs-derived NPCs from 3 pairs of dizygotic discordant twins for Congenital Zika syndrome 10.97
SILAC identifies LAD1 as an oncogenic filamin binder regulating actin dynamics in response to EGF and marking aggressive breast tumors 10.96
Self-organization of polarized cerebellar plate neuroepithelium in three-dimensional culture of human pluripotent stem cells 10.75
Conserved roles for murine mDUX and human DUX4 in activating cleavage stage genes and MERVL/HERVL retrotransposons [RNA-Seq Human] 10.63
Zika virus directly infects human peripheral neurons and induces cell death 10.59
Regulation of DNA methylation landscape in human somatic cell reprogramming by miR-29 family 10.57
Regulation of DNA methylation landscape in human somatic cell reprogramming by miR-29 family (RNA-seq) 10.57
Transcriptomic analysis to underly the heterogeneity between 4 cellular models derived from patients diagnosed with pediatric high-grade gliomas under controlled atmosphere (modulation of oxygen level). 10.57
The effect of spontaneous acquisition of an extra chromosome 7 for engineered del(7q) on induced pluripotent stem cells (iPSCs) derived from patients with Shwachman Diamond Syndrome (SDS). 10.48
Dissecting the dynamics of signaling events in the BMP,WNT and NODAL cascade during self-organized fate patterning in human gastruloids 10.37
RNA-seq of UGP2 mutant human embryonic stem cells and in vitro differentiated neural stem cells 10.28
A myogenic double reporter human pluripotent stem cell line allows prospective isolation of skeletal muscle progenitors 10.27
Supraphysiological Androgens Repress Prostate Cancer Growth and Induce DNA Damage Augmented by PARP Inhibition 10.23
Comprehensive analysis of Long non-coding RNA expression in dorsal root ganglion reveals cell type specificity and dysregulation following nerve injury 10.22
Comprehensive analysis of Long non-coding RNA expression in dorsal root ganglion reveals cell type specificity and dysregulation following nerve injury [human iPS] 10.22
Small-molecule-based Human Genome G4 Profiling Reveals Potential Gene Regulation Activity 10.2
Isogenic patient-derived human iPSCs, wild-type or heterozygous for PIK3CA-E418K 10.06
Regulation of mRNA half-life by an inhibitor of human decapping enzyme Dcp2 following transcription shutoff in HEK293T cells 10.0
Global transcriptome analysis of HAP1 cells 9.91
Preliminary Report of Transplantation of Human Fetal Retinal Pigment Epithelial Cells on Age-related Macular Degeneration Patients 9.8
α Cell Function and Gene Expression Are Compromised in Type 1 Diabetes 9.73
Modeling Trilateral Retinoblastoma using Human Embryonic Stem Cells 9.58
Serotonin-induced hyperactivity in SSRI-resistant major depressive disorder patient-derived neurons 9.57
Transcriptome analysis of H9 hESC derived cerebral organoids 9.55
Transcriptome analysis of diverse cell types infected with human cytomegalovirus [RNA-Seq] 9.52
mRNAseq of Huntington's disease and control patient iPSC-derived neural cells 9.5
Transcriptomic and Epigenomic analysis of Huntington's disease and control patient iPSC-derived neural cells 9.5
Transcriptome analysis of human immortilized astrocytes reprogrammed into dopaminergic neurons 9.37
Transcriptome analysis of Jurkat T-ALL clones from control and CBAP-knockdown/knockout sets 9.37
mRNA sequencing of the global effect of SOX2 on gene expression in hESC and hESC derived NPCs. 9.32
RNA-seq of HDAC2-disrupted 293FT cells by CRISPR-Cas9 9.0
Glioma Stem Cell Specific Super Enhancer Drives Polyunsaturated Fatty Acid Synthesis to Support EGFR Signaling 8.97
Global Regulation of Alternative Internal Exon Usage by mRNA 3' End Formation Factors [RNA-Seq] 8.96
Global Promotion of Alternative Internal Exon Usage by mRNA 3' End Formation Factors 8.96
TRIM28-Regulated Transposon Repression Is Required for Human Germline Competency and Not Primed or Naive Human Pluripotency 8.96
Quantitative comparison between cellular mRNAs and exosomal mRNAs in human iPSC-derived motor neurons 8.92
Gene expression profiles of ibrutinib-responsive and ibrutinib non-responsive cells in ERBB4 expressing cancer cell lines 8.8
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation [ChrRNA-seq] 8.67
Divergent effects of eRF3 and Upf1 on the expression of uORF carrying mRNAs and ribosome protein genes 8.6
A prostate cancer chromatin interaction map 8.6
Transcriptional dependencies in diffuse intrinsic pontine glioma 8.48
Neuronal brain region-specific DNA methylation and chromatin accessibility are associated with neuropsychiatric trait heritability 8.25
Neuronal brain region-specific DNA methylation and chromatin accessibility are associated with neuropsychiatric trait heritability [RNA-Seq] 8.25
Differential responses of human fetal brain neural stem cells to Zika virus infection 8.2
RNA-seq of naive and primed ES cells 8.2
Integrated multi-omics approach reveals a role of ALDH1A1 in lipid metabolism in human colon cancer cells 8.16
Transcriptome variation among human embryonic stem cell lines impacts on their differentiation 8.11
Detailed genomic and molecular characterization of Indian induced pluripotent stem cell lines 8.04
The m 6 A-methylase complex recruits TREX and regulates mRNA export. 8.04
R430: A potent inbibitor of DNA and RNA viruses 8.03
‘Naïve’ ESRRB+ iPSCs with the capacity for rapid neural differentiation 8.01
The Polycomb protein BMI1 induces an invasive gene expression signature in melanoma that promotes metastasis and chemoresistance. 7.97
Effect of CHKA knockdown on C4-2 cell transcriptome 7.96
The histone H3.3K27M mutation in pediatric glioma reprograms H3K27 methylation and gene expression 7.94
Differential expression in LNCaP cells expressing the wild-type androgen receptor (AR-WT) or the ligand-independent AR-V7 splice variant 7.93
mRNA differential expression in LNCaP cells expressing the wild-type androgen receptor (AR-WT) or the ligand-independent AR-V7 splice variant 7.93
RNA-seq analysis of SKMEL28 melanoma cells following DIRC3 and IGFBP5 ASO knockdown 7.89
ADAR1 controls apoptosis of stressed cells by inhibiting Staufen-mediated mRNA decay 7.86
Transcriptome analysis of human embryonic stem cells (hESCs) and human fibroblasts upon rapamycin 7.86
SETBP1-WT and SETBP1-G870S transcriptional profiles [RNA-Seq] 7.84
SETBP1-WT and SETBP1-G870S epigenetic landscapes 7.84
Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma 7.82
Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma [RNA-seq] 7.82
Comparative whole-transcriptomic analysis between normal and AKAP-Lbc-depleted human embryonic stem cells 7.8
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer (BRD4_JQ1_RNA-seq) 7.64
RNA-Seq of cKIT+ sorted cells from 53-137 day old fetal testes and ovaries and RNA-Seq of TRA-1-81+ H1 and UCLA1 hESCs. 7.58
cKIT+ sorted cells from 57-137 day old fetal testes and ovaries 7.58
Neurofibroma 7.57
Differential expression in wild-type and mutant neurofibroma and MPNST cell lines 7.57
ASCL1 mediates neuronal differentiation of primary GBM stem cell cultures upon Notch signalling blockade [RNA-seq] 7.55
Transcriptional responses of human insulinoma cells to acute cytokine exposure 7.5
Comprehensive Transcriptome Analysis of Cerebral Cavernous Malformation Across Multiple Species and Genotypes 7.49
Maintaining iron homeostasis is the key role of lysosomal acidity for cell proliferation 7.48
RNA-Seq of cKIT+ sorted cells from 16-16.5 week old fetal testes and ovaries and RNA-Seq of TRA-1-60+ H1 hESCs 7.45
S-adenosyl-methionine treatment selectively block liver cancer cell lines transformation and invasiveness by alterations of cancer- and invasion specific transcriptome and methylome 7.35
S-adenosyl-methionine treatment selectively block liver cancer cell lines transformation and invasiveness by alterations of cancer- and invasion specific transcriptome and methylome (RNA-Seq) 7.35
CREB5 promotes resistance to androgen-receptor antagonists and androgen deprivation in prostate cancer 7.3
Single-cell Transcriptomic Atlas of the Human Retina Identifies Cell Types Associated with Age-Related Macular Degeneration 7.29
Transcriptional profiles of human blood dendritic cell (DC) subsets at steady state 7.28
Transcriptome analyses of human pancreatic islets and pseudoislets 7.27
N6-methyladenine DNA Modification in Glioblastoma 7.26
N6-methyladenine DNA Modification in Glioblastoma [RNA-seq] 7.26
Receptor tyrosine kinase signaling promotes post-embryonic morphogenesis and survival of glia and neural progenitor cells 7.25
Transcriptome analysis reveals determinant stages controlling human embryonic stem cell commitment to neuronal cells 7.24
hESC neural differentiation 7.18
RNA-seq analysis of gene expression patterns during hESC neural differentiation 7.18
The Glioma-Infiltrating T Cell Receptor Repertoire 7.08
Next Generation Sequencing of isolated EGFR+ and HLA-G+ first trimester human trophoblasts 7.07
Patient-derived luminal breast cancer xenografts with progestins 7.04
RNAseq analysis of patient-derived luminal breast cancer xenografts treated with progestins 7.04
Whole transcriptome RNA sequencing of human cells after HCV infection (ML-1 thyroid cell line, primary thyrocytes and Huh7.5 hepatocyte cell line) 6.99
RNA helicase A is necessary for KIF1Bβ tumor suppression in neuroblastoma 6.98
Transcriptome profiling of H1-iCas9 cells grown on laminin and on MEFs 6.95
RNA-seq of SCLC PDX models treated with EP 6.93
LncPRESS1 is a p53-regulated lncRNA that safeguards pluripotency by disrupting SIRT6 mediated de-acetylation of histone H3K56 6.9
3’ Uridylation Expands miRNA Target Repertoire 6.72
The RNA-binding profile of Acinus, a peripheral component of the Exon junction complex, reveals its role in splicing regulation 6.71
Identification of long noncoding RNAs regulated by p53 6.68
RNA-seq analyses of human prostate cancer cells 6.66
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L 6.63
Primate-specific gene TMEM14B promotes cortical expansion and folding 6.62
CUREfast: Accelerating research with families 6.6
Effect of TUNAR silencing and GSK3 inhibition on human b-cell transcriptome 6.59
Paxillin regulates genomic networks in prostate cancer [LNCaP] 6.41
A transcriptome-wide divergence in protein translation scales with LIN28B expression 6.37
To identify transcripts that are differentially expressed in the MYCN amplified vs MYCN non-amplified cell lines using Next Generation Sequencing 6.37
mRNA-seq from Nutlin-3a, doxorubicin, and DMSO treated HCT116 p21-/- cells 6.36
Network-based, cross-cohort discovery of transcriptional mechanisms presiding over maintenance of high-risk neuroblastoma subtype state 6.33
Characterization and therapeautic application of mesenchymal stem cells with neuromesodermal origin from human pluripotent stem cells 6.33
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 6.29
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 (RNA-seq data sets) 6.29
Large-Scale Atlas of Mutant IDH1-Dependent Chromatin State Reprogramming, Reversibility, and Persistence [RNA-seq] 6.23
Large-Scale Atlas of Mutant IDH1-Dependent Chromatin State Reprogramming, Reversibility, and Persistence 6.23
Expression profiling and occupancy after knockdown or over-expression of HFN1A or HNF4G in prostate cancer cells 6.22
Comparison between THP-1 cells obtained from either ATCC or DSMZ biorepository 6.22
An integrative analysis of non-coding regulatory DNA variations associated with autism 6.2
The Unfolded Protein Response Regulator, ATF6, Promotes Mesodermal Differentiation 6.15
Identification of an IL-1-induced gene expression pattern in AR+ PCa cells that mimics the molecular phenotype of AR- PCa cells 6.13
Huntingtin aggregation impairs autophagy leading to Argonaute-2 accumulation and global microRNA dysregulation 6.12
Reduced CYFIP1 in human neural progenitors as 15q11.2 deletion model: donor specific dysregulation of schizophrenia/epilepsy genes 6.12
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice [HCT116_RNA-seq] 6.1
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice 6.1
A novel lncRNA lncRNA-AK096729 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc 6.09
Gene expression profiles of isogenic single-cell derived clones of BRAF-mutated SK-MEL-5 melanoma cell lines 6.05
High throughput characterization of the m6A demethylase FTO by CLIP and RNAseq 6.0
Differential gene expression tools exhibit substandard performance for long non-coding RNA-sequencing data 5.97
Discovery of cis-spliced chimeric RNAs between adjacent genes in human prostate cells 5.94
Enriched retinal ganglion cells derived from human embryonic stem cells (RNA-seq) 5.92
High-efficiency RNA-based reprogramming of human primary fibroblasts 5.91
Modeling and characterization of the dynamic gene regulatory networks underlying cancer drug resistance based on time-course RNA-seq data 5.88
Identification of novel recurrent ETV6-IGH fusions in primary central nervous system lymphoma using high throughput RNA sequencing 5.88
H3.3K27M cooperates with p53 loss and Pdgfra gain in mouse embryonic neural progenitor cells to induce invasive high-grade gliomas [Human RNA-Seq] 5.88
H3.3K27M cooperates with p53 loss and Pdgfra gain in mouse embryonic neural progenitor cells to induce invasive high-grade gliomas 5.88
Genome-wide RNA-sequencing of human islets 48 hour after transduction with adenoviruses expressing either GFP (control), or histone chaperone ASF1B. 5.87
Rna-seq transcriptome data for insulin-GFP+ cells differentiated from NEUROD1 knock out and NEUROD1+/+ control human embryonic stem cells. 5.87
NEUROD1 dependent gene regulation in murine pancreatic endocrine cells and human stem cell derived insulin producing cells 5.87
RNA-Guided Human Gene Activation by Cas9/CRISPR-Based Engineered Transcription Factors 5.81
FGF2 regulation of gene expression in stable inducible Neurons 5.8
Zika infected neural stem cells 5.78
Transcriptome analysis of Zika infected neural stem cells 5.78
O-glcnAc reprograms cellular energetics 5.75
The effect of insulin on mRNA transcription of human pluripotent stem cells 5.75
lncRNA-PCAT1 knockdown effect on the gene expression of androgen independent LNCaP (LNCaP-AI) cell line 5.69
Global gene expression profiles of cardiac progenitors differentiated from human pluripotent stem cells in 3D culture under simulated microgravity 5.67
Genome-wide maps of m6A circRNAs identify widespread and cell-type-specific methylation patterns that are distinct from mRNAs 5.66
Hierarchy of mono- and bi-allelic TP53 alterations in Multiple Myeloma cell fitness 5.64
Biomarkers of Cavernous Angioma with Symptomatic Hemorrhage (CASH) 5.64
Biomarkers of Cavernous Angioma with Symptomatic Hemorrhage (CASH) [RNA-seq] 5.64
Transcriptome analysis of PRMT6 knock-out in NT2/D1 cells 5.62
Genomic location of PRMT6-dependent H3R2 methylation is decisive for the transcriptional outcome of associated genes 5.62
Directed differentiation of human embryonic stem cells to corneal endothelial cell-like cells: A transcriptomic analysis 5.59
Human pluripotent stem cell-derived brain tumor model uncovered embryonic stem cell signature as a key driver in atypical teratoid/rhabdoid tumor (RNA-Seq) 5.59
SOX21 ensures rostral forebrain identity by suppression of WNT8B during neural regionalization of human embryonic stem cells 5.58
Histone deacetylase inhibition enhances antimicrobial peptide but not inflammatory cytokine expression upon bacterial challenge 5.5
Smad5 acts as an intracellular pH messenger and maintains bioenergetic homoeostasis 5.46
PT2385 HIF2A inhibitor treatment of patient derived orthotopic xenograft neuroblastoma cells in the presence or absence of hypoxia 5.39
Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition [RNA-Seq] 5.35
Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition 5.35
Functional role of SLIT2 and ROBO1 in trophoblasts 5.32
Response of HEK293 Freestyle cells to 36 h of culture in Zn(II)-depleted Freestyle medium 5.28
Major hnRNP proteins act as general TDP-43 functional modifiers both in Drosophila and human neuronal cells. 5.27
RNA-seq analysis of human KMT2A rearranged MV4;11 AML cell line treated with DOT1L and/or EZH2 inhibitor 5.26
Reprogramming by de-bookmarking somatic transcriptional program via targeting the BET bromodomains 5.24
Human embryonic stem cell, chimpanzee induced pluripotent stem cell, orangutan induced pluripotent stem cell, rhesus embryonic stem cell, and their derived cortical organoid RNA-seq 5.23
Generation of mature lung alveolar epithelial cells from human pluripotent stem cells 5.22
Enriched EWSR1 and EWS-FLI1 RNA-seq of HNRNPH1-silenced TC32 Ewing sarcoma and 293T human embryonic kidney cells. 5.2
Suppression of NAF-1 in Breast Cancer Cells Reduces their Tumorigenicity by Interfering with Cellular Iron Distribution and Metabolism and Ensuing ROS Formation and Apoptosis 5.19
Identification of transcripts altered upon LIN-41 knockdown in human embryonic stem cells 5.12
Human naïve pluripotent stem cells exhibit X chromosome dampening and X-inactivation (RNA-Seq) 5.08
TMED9-gated CNIH4 and TGFa signaling promotes pro-metastatic states in human primary colon cancer cells 5.08
iPSC-Derived Cholangiocytes 5.07
RNA-seq analysis of RALD iPSCs after in vitro differentiation 5.07
Genome-wide analysis of YAP and TFCP2 down-regulated genes in liver cancer cells 5.06
Genome-wide analysis of YAP and TFCP2 occupancy and regulated expression in liver cancer cells 5.06
Landscape of Hematopoiesis Described in Induced Pluripotent Stem Cells and Human Bone Marrow 5.04
The E3 ubiquitin ligase HectD1 suppresses EMT and metastasis by targeting the +TIP protein ACF7 for degradation 5.02
Next Generation Sequencing Facilitates Quantitative Analysis of mesoderm posterior bHLH transcription factor 1(MESP1)+ and MESP1- cells' Transcriptomes 5.01
RNA-sequencing of the brain transcriptome implicates dysregulation of neuroplasticity, circadian rhythms, and GTPase binding in bipolar disorder 4.98
Resistance to BET inhibitor leads to new therapeutic vulnerabilities in castration resistant prostate cancer 4.92
m6A level and isoform characterization sequencing (m6A-LAIC-seq) reveal the census and complexity of the m6A epitranscriptome 4.88
Locally transplanted human urine-induced nephron progenitor cells contribute to renal repair in mice kidney with diabetic nephropathy 4.87
Gene-Edited Human Kidney Organoids Reveal Mechanisms of Disease in Podocyte Development 4.81
Trans-differentiation of human adult peripheral blood T cells into neurons 4.79
Dissecting neural differentiation regulatory networks through epigenetic footprinting 4.78
Analysis of human ES cell differentiation establishes that the dominant isoforms of the lncRNAs RMST and FIRRE are circular 4.77
UTX and 53BP1 co-regulate genetic programs for neural differentiation of human embryonic stem cells [RNA-seq] 4.69
UTX and 53BP1 co-regulate genetic programs for neural differentiation of human embryonic stem cells 4.69
Derivation and differentiation of haploid human embryonic stem cells [RNA-Seq 1] 4.67
HuR controls apoptosis and activation response without effects on cytokine 3′ UTRs 4.67
Transcriptome-wide identification of CELF2 functional targets in T cells 4.67
The acetyllysine reader BRD3R promotes human nuclear reprogramming and regulates mitosis 4.66
RNA-seq in neurons derived from iPSCs in controls and patients with schizophrenia and 22q11 del 4.6
Disruption of the TFAP2A regulatory domain causes Branchio-Oculo-Facial Syndrome (BOFS) and illuminates pathomechanisms for other human neurocristopathies 4.58
RNA binding protein CPEB1 remodels host and viral RNA landscapes [RNA-Seq] 4.57
Gene expression profiling of LNCaP cells following shRNA-mediated knockdown of TMEFF2 and growth in presence and absence of dihydrotestosterone 4.57
Transcription-dependent control of stem cell self-renewal and differentiation by the splicing factor U2AF1 4.56
Characterization of human mosaic Rett syndrome brain tissue by single-nucleus RNA sequencing (Total RNA sequencing) 4.49
EZHIP constrains Polycomb Repressive Complex 2 activity in germ cells (RNA-Seq) 4.48
EZHIP constrains Polycomb Repressive Complex 2 activity in germ cells 4.48
Neural cell adhesion molecule 1 (NCAM1; CD56) promotes leukemogenesis and confers drug resistance in acute myeloid leukemia. 4.46
RNA-seq analysis of hPSC-derived brain pericyte-like cells, hPSC-derived neural crest stem cells, and primary human brain pericytes 4.45
Total RNA sequencing of prospective axial stem cell cultures derived from human pluripotant stem cells 4.43
Functional Haploid Human Oocytes Generated from Polar Body Genomes (RNA-Seq) 4.42
Functional Haploid Human Oocytes Generated from Polar Body Genomes 4.42
Comparing gene expression in iPSC derived RPE from control and AMD donors 4.4
RNA-seq of human iPS derived macrophages with or without KLF1- transcription factor Activation 4.37
NHLRC1 re-expression in cancer cells 4.35
The lipodystrophic hotspot lamin A p.R482W mutation deregulates the mesodermal inducer T/Brachyury and early vascular differentiation gene networks 4.3
Functional significance of the HIV-1 Tat signature amino acid residues 4.3
Cranial pericytes derived from neural crest cells reveal an inherent cell type-specific defect in Alzheimer's Disease 4.24
Histone Demethylase-Assisted Somatic Cell Nuclear Transfer Facilitates Derivation of Human Pluripotent Stem Cells 4.24
AMPK signaling for naïve pluripotency 4.21
AMPK signaling for naïve pluripotency [Hs] 4.21
Characterization of EZH2-deficient human embryonic stem cells [ChIP-seq and bulk RNA-seq] 4.2
Control of prostate tumour growth by the long non-coding RNA GHSROS (LNCaP) 4.14
Transcriptome data from human endocrine cells recovered from mouse grafts with pre-engraftment controls 4.1
PRDM1 inhibits proliferation of human colon cancer organoids 4.08
ONECUT2 Drives Neuroendocrine Prostate Cancer Through Hypoxia Signaling 4.07
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells [RNA-seq] 4.05
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells 4.05
Single-Cell Transcriptome Analysis of Lineage Diversity and Microenvironment in High-Grade Glioma 3.98
Alternative classification of glioblastoma based on BUB1B-inhibition sensitivity 3.94
A specific missense mutation in GTF2I occurs at high frequency in thymic epithelial tumors 3.94
Co-regulation of splicing by Rbfox1 and hnRNP M 3.94
Co-regulation of splicing by Rbfox1 and hnRNP M [hnRNPM k-d+Rbfox1 RNA-Seq] 3.94
Targeted differentiation of regional ventral neuroprogenitors and related neuronal subtypes from human pluripotent stem cells 3.92
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration 3.92
RNAseq analysis of ESRP regulated splicing events in prostate cancer 3.87
Integration of kinase and calcium signaling at the level of chromatin underlines inducible gene activation in T cells 3.86
RNA-Seq characterization of human H1-derived NPC differentiation timecourse 3.79
SQSTM1/p62-directed metabolic reprogramming is essential for normal neurodifferentiation 3.74
Bach1 Regulates the Self-renewal and Mesendodermal Differentiation of Human Embryonic Stem Cells 3.71
Overexpression and knockdown experiment for circCSNK1G3 3.69
RNA sequencing for human induced pluripotent stem cell cardiomyocyte differentiation 3.65
Cerebellar differentiation in Ataxia-Telangiectasia 3.65
Antiviral innate immunity of hepatitis C virus-infected stem cell-derived hepatocytes 3.61
Class I histone deacetylases HDAC1, 2 and 3 are histone decrotonylases 3.5
Characterization and transplantation of enteric neural crest cells from human induced pluripotent stem cells 3.48
Next Generation Sequencing of human SMA and healthy control Motor Neurons 3.45
In vitro modeling of human germ cell development using pluripotent stem cells 3.41
Global Transcriptional analysis of human spinal cord and neocortical neuroepithelial stem (NES) cells 3.39
Human stem cell based models of neuronal migration provide insight into neurological disease pathogenesis and potential treatment 3.28
Transcriptomics profiling of CD141+ dendritic cells isolated from peripheral blood or synovial fluid of arthritis patients 3.28
Genome-scale screens identify JNK/JUN signaling as a barrier for pluripotency exit and endoderm differentiation 3.22
Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state. 3.2
Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state. 3.2
The chromatin modifier CHD8 targets autism risk genes during human neurodevelopment  3.13
An aspartyl protease defines a novel pathway for export of Toxoplasma proteins into the host cell 3.11
RNA-Seq Analysis in hES/ iPS cell-derived neuronal samples 3.09
Next Generation Sequencing Analysis of human embryonic stem cells derived MESP1-mTomato reporter cells 3.07
Human-specific gene ARHGAP11B promotes basal progenitor amplification and neocortex expansion 3.07
LEDGF and HDGF2, histone H3K36 methyl-binding proteins that assist RNA polymerase II transcription through nucleosomes 2.96
Rapid neurogenesis through transcriptional activation in human stem cell (RNA-Seq) 2.9
Transcriptomic analysis of human neural progenitor cells differentiation into astrocytes 2.87
Gene expression regulated by CSA and CSB in neuroblastoma cell line 2.86
Evaluation of RNA amplification and RNA-Seq library preparation protocols for spermatozoa RNA profiling 2.85
PRC2 specifies ectoderm lineages and maintains pluripotency in primed but not naïve ESCs 2.84
Transposon-based construction of strand-specific RNA-seq libraries 2.83
The role of CFTR in islet function 2.76
RNA-Seq of the corpus callosum from 12 individuals 2.75
Analysis of human, chimpanzee, macaque and mouse tissue transcriptomes using Next Generation Sequencing 2.73
Global reduction in H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomas 2.73
The anti-leukemic effect of R-2HG depends on its acting as an m6A mRNA modifier-RNA Seq-PBS / R-2HG treatment 2.72
A SRp55-regulated alternative splicing network controls pancreatic beta cell survival and function 2.65
Research resource: global identification of estrogen receptor β target genes in triple negative breast cancer cells 2.64
RNAseq in Alzheimer's Disease patients 2.63
FMR1 reactivating treatments in Fragile X iPSC-derived neural progenitors in-vitro and in-vivo 2.56
Transcriptome-wide discovery of microRNA binding sites in human brain by Ago2 HITS-CLIP 2.47
A runaway PRH/HHEX-Notch3 feedback loop drives cholangiocarcinoma (RNA-Seq) 2.43
Non-coding and coding transcriptional profiles are significantly altered in pediatric Retinoblastoma tumors 2.43
Transcriptomics analysis of gene expression in normal and METTL3 or WTAP deficient Human HeLa cells 2.39
Critical role for Lymphocytes in Producing FLT3LG in Tumors and Driving Checkpoint Therapy-Receptive Immune Microenvironments 2.37
Robust prediction of response to immune checkpoint blockade therapy in metastatic melanoma 2.3
Transcriptome analysis of diverse cell types infected with human cytomegalovirus 2.3
LncRNA NMR knockdown and overexpression in esophageal squamous cell carcinoma cell lines 2.28
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-Seq KO] 2.22
Identification of expressed and conserved human non-coding RNAs 2.18
Reversing Abnormal Neural Development by Inhibiting OLIG2 in Down Syndrome Human iPSC Brain Organoids and Neuronal Mouse Chimeras 2.14
Total RNAseq of human putamen and caudate nucleus tissues in healthy control and Bipolar Disorder individuals 2.11
Alarmin S100A11 initiates a chemokine response to the human pathogen Toxoplasma gondii 2.08
A compendium of promoter-centered long-range chromatin interactions in diverse human tissues and cell types 2.08
Necroptosis inhibition protects from dopaminergic neuronal cell death in OPA1 mutant Parkinson’s disease patient neurons and MPTP treated mice 2.01
Cis-SAGe fusion RNAs in transcription splicing factors knocking-down 293T cells 1.99
An acquired vulnerability of drug resistant melanoma with therapeutic potential 1.99
RNA Seq data: A375, A375R, A375DR vorinostat treated, and biopy samples from patients pre- and post- treated with Vorinostat 1.99
Paclitaxel plus Cirmtuzumab Achieves Greater Clearance of Patient-derived Xenografts By Targeting ROR1+ Breast Cancer Stem Cells 1.98
Transcriptome analyses of iPSC-derived neural stem/progenitor cells and cerebral organoids from monozygotic twins discordant for schizoaffective bipolar disorder 1.96
Post-transcriptional remodelling is temporally deregulated during motor neurogenesis in human ALS models 1.94
Global transcriptional analysis of human extended pluripotent stem cells, human primed pluripotent stem cells, mouse extended pluripotent stem cells, and mouse embryonic stem cells by RNA-seq 1.9
Global transcriptional analysis and genome-wide analysis of chromatin state in extended pluripotent stem cells, primed pluripotent stem cells, and naïve pluripotent stem cells 1.9
Comparison of 7 small cell lung cancer PDX models, cultured ex vivo, for response to LSD1 inhibitor RG6016/ORY1001 1.88
An Argonaute phosphorylation cycle promotes microRNA-mediated silencing [polyA RNA-seq] 1.87
The impact of pro-inflammatory cytokines on the β-cell regulatory landscape provides insights into the genetics of type 1 diabetes 1.83
Coding mutations and loss-of-imprinting in human pluripotent cells derived by nuclear transfer and defined factors 1.76
Coding mutations and loss-of-imprinting in human pluripotent cells derived by nuclear transfer and defined factors [RNA-Seq] 1.76
Impact of library preparation on downstream analysis and interpretation of RNA-seq data: comparison between Illumina PolyA and NuGEN Ovation protocol 1.74
Dynamics of Proteo-Transcriptomic Response to HIV-1 Infection 1.73
BioProject PRJNA381064: Convergent origination of a Drosophila-like dosage compensation mechanism in a reptile lineage (Gene expression profiling in several tetrapod species, bulk tissue RNA-seq) 1.67
Gene expression and genome-wide location analysis of breast cancer cell-lines 1.64
Gene expression analysis of breast cancer cell-lines 1.64
Molecular Criteria for Defining the Naive Human Pluripotent State 1.56
Induced pluripotent stem cell modeling of bone marrow failure and MDS identifies therapeutic targets 1.54
RNAseq of Breast cancer PDX samples 1.52
single cell RNA-seq from GM12878 (ENCSR673UIY) 1.47
RNA-seq and small RNA-seq from WT and ADAR1 knockdown H9 lines and their differentiation to specific types of neurons 1.4
Increased Neanderthal ancestry in genomic regions associated with lipid catabolism in contemporary Europeans 1.36
Transcriptomic analysis of human iPS cells derived from fragile X syndrome patients during neural differentiation 1.34
RNAseq analysis of ruxolitinib treated breast cancers 1.34
The expression of genes encoding palmitoylated proteins in axonal and synaptic compartments is affected in CLN1/PPT1 transfected neuronal cells 1.31
Engineering Patient-Specific Tissue Implants 1.26
RNA-seq of cancer cell lines treated with T-025 1.17
Expression alterations induced by restoration of AXIN1 expression in SNU449 hepatocellular carcinoma cells 1.17
RNA sequencing of hiPSC derived neural crest populations from Familial Dysautonomia patients 1.15
Disruption of the TFAP2A regulatory domain causes Branchio-Oculo-Facial Syndrome (BOFS) and illuminates pathomechanisms for other human neurocristopathies [RNA-seq data set 2] 1.1
Effects of Spaceflight on Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Structure and Function 0.99
Transcriptome-wide discovery of microRNA binding sites in human brain by Ago2 HITS-CLIP [Ago2-miRNA-target mRNA complexes] 0.98
Evaluation of the effectiveness of semen collection and sperm purification methods for spermatozoa transcript profiling 0.96
The MEF2B Regulatory Network - RNA-seq data 0.86
The MEF2B Regulatory Network 0.86
Single amino acid change underlies distinct roles of H2A.Z subtypes in human syndrome 0.84
RNA-Seq in PWS iPSC-derived neurons 0.83
The DNA methylation landscape of human melanoma 0.83
The DNA methylation landscape of human melanoma [RNA-Seq] 0.83
Expression profiles of the four human major ectodermal lineages 0.81
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-seq] 0.77
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (LNCaP RNA-seq) 0.77
The Dynamic Epigenetic Landscape of the Retina During Development, Reprogramming, and Tumorigenesis 0.74
The Dynamic Epigenetic Landscape of the Retina During Development, Reprogramming, and Tumorigenesis [RNA-Seq_Hs] 0.74
Next Generation Sequencing Compares Effects of microRNA-9 perturbation in control and SZ hiPSC NPCs 0.73
STX4 Over-Expression in Human islets 0.72
The SS18-SSX fusion oncoprotein hijacks BAF complex targeting and function to drive synovial sarcoma [RNA-Seq Tumor] 0.72
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer 0.71
Derivation and differentiation of haploid human embryonic stem cells 0.64
Gene Expression Profile of human hepatocellular carcinoma by RNA sequencing 0.64
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration [RNA-seq2] 0.62
DAOY-Notch1/Notch2 knockout: transcriptome comparison 0.6
Single cell transcriptomics analysis of induced pluripotent stem cell-derived cortical neurons reveals frequent dual layer identity 0.58
Genome-wide Circadian Control of Transcription at Active Enhancers Regulates Insulin Secretion and Diabetes Risk 0.58
Pancreatic Beta Cell Enhancers Regulate Rhythmic Transcription of Exocyst Triggering and Diabetes 0.58
Widespread regulated alternative splicing of single codons accelerates proteome evolution 0.5
Identification of microRNA-dependent gene regulatory networks driving human pancreatic endocrine cell differentiation [H1 RNA-seq] 0.47
An Alternative Splicing Event Amplifies Evolutionary Differences Between Vertebrates 0.47
Comparative analysis of WT and ZEB1 KO cells in different stages during differentiation 0.42
A combinatorial screen of the CLOUD uncovers a synergy targeting the androgen receptor 0.41
N6-methyladenosine (m6A) profiling of EndoC-bH1 cell line and RNA seq of Mettl14 knockout mice beta cell 0.39
Cell cycle positioning drives heterogeneity within the pluripotent stem cell compartment 0.37
Efficient derivation of microglia-like cells from human pluripotent stem cells 0.35
Differential LINE-1 retrotransposition in induced pluripotent stem cells between humans and great apes 0.31
CD133hi, Notchhi, DP (double positive) and DN (double negative) in GBML8 and GBML20, both patient-derived glioblastoma tumorsphere cultures 0.3
Enhancer divergence and cis-regulatory evolution in the human and chimpanzee neural crest 0.25
Proteomics identifies a marker signature of MAPKi resistance in melanoma 0.25
Gene expression profiles of active and restricted R/G-HIV+ primary human fetal astrocytes 0.22
hNSCs siRNA NOVA2 0.22
Identifying markers predicting successful graft outcome for clinical translation of hESC-based cell therapy for Parkinson’s disease 0.18
The age and genomic integrity of neurons after cortical stroke in humans 0.16
Mechanism suppressing H3K9 trimethylation in pluripotent stem cells and its demise by polyQ-expanded huntingtin mutations [RNA-seq] 0.16
Mechanism suppressing H3K9 trimethylation in pluripotent stem cells and its demise by polyQ-expanded huntingtin mutations 0.16
Low H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomas 0.11
RNA-seq of H9-hESC derived human neural stem cells with combinations of mutant IDH1-R132H overexpression, P53 shRNA knockdown and/or ATRX shRNA knockdown 0.08
H9-hESC derived human neural stem cells with combinations of mutant IDH1-R132H overexpression, P53 shRNA knockdown and/or ATRX shRNA knockdown 0.08
Integrated Multi-omic Analysis of Esthesioneuroblastomas Identifies Two Subgroups Linked to Cell Ontogeny 0.08
Arnica montana stimulates extracellular matrix gene expression in human macrophages differentiated to wound-healing phenotype. 0.05
A Phase II Study of Pomalidomide, Daily Low Dose Oral Cyclophosphamide, and Dexamethasone in Relapsed/Refractory Multiple Myeloma 0.04
RelA mutants 'reconstituted' and cell cycle synchronized HCT116 Colorectal Cancer Cells 0.03
Stranded RNA-seq were performed on total RNA following ribosomal RNAs depletion (Ribo-zero removal kit, illumina) for 3 brain , 8 IDHwt and 5 IDHmut glioma samples. 0.02
Interferon receptor signaling pathways regulating PD-L1 and PD-L2 expression 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation